Champion trusted data that drives confident decisions

In this role, you help ensure that every business insight across Resmed is built on reliable, transparent, and well‑understood data. As part of the Data Insights team within our Commercial Insights and Data Science organization, you connect data sources, analytics teams, and business stakeholders to create a single version of truth. Your work supports smarter decisions that help us deliver innovative solutions to patients, providers, and partners.

You will bring clarity to complex data landscapes—supporting the development and adoption of standardized metrics, validating data quality, reconciling inconsistencies, and embedding repeatable integrity checks that enhance confidence in analytics and enterprise reporting. This is an opportunity to combine technical expertise with business understanding and communication skills to translate complex data issues into clear findings, recommendations, and solutions; hence enabling the entire organization to make decisions based on trusted information.

What You’ll Do

Partner with business, analytics, product, and technical stakeholders to define data requirements, metric definitions, business rules, and use cases.
Validate internal and external data sources for accuracy, consistency, completeness, and usability with minimal supervision.
Investigate and reconcile discrepancies across multiple datasets and reporting environments, identify root causes and recommend remediation.
Develop, maintain, and enhance repeatable validation processes, reconciliation methodologies, and quality controls for critical business data.
Validate new datasets, metrics, dashboards, and analytical products prior to broader adoption, and collaborate with data engineering and analytics teams to address upstream data quality issues.
Monitor key datasets and metrics for anomalies, gaps, unexpected changes, and emerging data quality concerns, and develop reporting tools that provide visibility into data integrity.
Support the development and governance of standardized enterprise metrics, definitions, and business rules, while maintaining clear documentation of data sources, lineage, methodologies, assumptions, and limitations.

Enable analysts and business partners to effectively access, understand, and use trusted data for analysis and insights-generation.
Translate complex technical findings into clear, non-technical language for business stakeholders and leadership to support informed decision-making.

What You Bring

Bachelor’s degree in information technology, data analytics, computer science, finance, statistics, business, or related field.
5+ years of experience in data analytics, business intelligence, data quality, data governance, or related analytical discipline.
Proficiency in SQL for investigating, identifying root causes of data discrepancies, validating, reconciling, and analyzing large and complex datasets across multiple systems.
Strong understanding of relational databases, data warehousing, data pipelines, and enterprise reporting environments, with the ability to connect technical data structures to underlying business processes.
Proven experience developing and applying data validation processes, quality assurance, business rules, and/or data governance practices in a business setting, to improve data accuracy and reliability.
Familiarity with BI tools such as Power BI or Tableau.
Strong analytical and problem-solving skills with exceptional attention to detail and the ability to clearly communicate complex data issues, methodologies, and findings to technical and non-technical audiences.
Strong interpersonal, collaboration, organizational, documentation, and time-management skills, with the ability to work effectively and influence across teams without direct authority.
Experience within healthcare, medical devices, or other complex data environments preferred.

What Sets You Apart

Data Stewardship Mindset - You treat data as a business asset and drive integrity across systems and teams.
Analytical Curiosity - You dig deep into data patterns and anomalies to uncover root causes.
Clear Communicator - You make complex data stories understandable and actionable for any audience.
Collaborative Approach - You build relationships across functions to align on definitions and outcomes.
Systems Thinker - You connect upstream sources to downstream analytics and reporting impacts.
Continuous Improver - You seek ways to enhance processes and ensure ongoing data reliability.

Why Join Resmed

At Resmed, your work helps shape how data supports better health outcomes worldwide. You’ll be part of a team that values collaboration, precision, and innovation through actionable insights. We believe trusted data leads to trusted decisions—and that confidence ultimately benefits patients, providers, and partners.

Benefits and Compensation

At Resmed, we're shaping the future by investing in our people through competitive pay, flexible work arrangements, and programs that support personal and professional growth.

Benefits (employees regularly scheduled to work 30+ hours per week) include:

Medical, dental, vision, life, AD&D, and disability insurance
HSA, FSA, commuter benefits, and sleep care management
401(k), ESPP, EAP, and tuition assistance

Flexible Time Off (FTO) for salaried employees

14 paid company holidays
Up to 14 weeks primary caregiver leave or 2 weeks secondary caregiver leave

Compensation: Compensation is based on geographic location, qualifications, experience, skills, and internal equity. Resmed generally does not hire at or near the top of the pay range.

Pay Range: $94,000 - $148,000 USD Annual

Eligible employees may have the opportunity to participate in incentive compensation programs, subject to applicable plan terms and eligibility requirements.

Joining us is more than saying “yes” to making the world a healthier place. It’s discovering a career that’s challenging, supportive and inspiring. Where a culture driven by excellence helps you not only meet your goals, but also create new ones. We focus on creating a diverse and inclusive culture, encouraging individual expression in the workplace and thrive on the innovative ideas this generates. If this sounds like the workplace for you, apply now!

About the company

ResMed creates cloud-connected medical devices and software platforms to treat and manage sleep apnea, COPD, and other chronic diseases. Its devices (like sleep therapy gear) collect patient data and deliver therapy, while connected software platforms enable remote monitoring, coaching, and caregiver support. The company sells medical devices and offers software subscriptions, generating revenue from product sales and ongoing service fees. Unlike some competitors, ResMed combines hardware with cloud-based analytics and a broad ecosystem that supports patients, healthcare professionals, and caregivers across more than 120 countries. Its goal is to improve patient care and quality of life while reducing hospital visits and overall healthcare costs.

Company Size

5,001-10,000

Company Stage

IPO

Headquarters

San Diego, California

Founded

1989

Get referred to Resmed

See people who can refer or advise you

Simplify's Take

What believers are saying

September 2026 guidance shows 5%-7% revenue growth and 12%-14% core EPS growth.
MatrixCare closed September 1, 2026, freeing capital for higher-margin core businesses.
ResMed's connected network and Oura partnership expand diagnosis and PAP adoption funnels.

What critics are saying

Astral no-new-sales in fiscal 2027 removes $75 million revenue and damages trust.
KPMG exit and PwC onboarding increase reporting disruption risk before the next 10-Q.
Philips Respironics' U.S. return in 2027 can compress pricing and share quickly.

What makes Resmed unique

ResMed's cloud-connected AirSense platform locks in recurring resupply and adherence data.
Noctrix acquisition broadens ResMed beyond apnea into restless legs syndrome treatments.
MatrixCare sale and core-device focus sharpen execution around sleep, breathing, and home care.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
Health Savings Account/Flexible Spending Account
Unlimited Paid Time Off
Paid Vacation
Paid Holidays
Parental Leave
401(k) Retirement Plan
Employee Assistance Program (EAP)

Growth & Insights and Company News

6 month growth

1 year growth

2 year growth

Yahoo Finance

Oct 23rd, 2026

ResMed launches AirTouch F40 mask in US, but analysts see only an incremental boost

ResMed has launched its AirTouch F40 CPAP mask in the US. The fabric-cushioned design connects to the company's myAir and AirView platforms and aims to improve comfort, adherence and fitting for obstructive sleep apnea patients. Existing AirFit F40 users can switch to the new ComfiSoft fabric cushion without a full refit. This could lift resupply activity and keep patients within ResMed's connected ecosystem. The launch looks incremental. Supply chain costs and the Astral ventilator remediation remain the main near-term risks, with a headwind expected in FY2027. From July to September 2026, ResMed retired 972,000 shares for $200 million. Analysts' narrative projects $6.6 billion in revenue and $1.9 billion in earnings by 2029.

GlobeNewswire

Oct 19th, 2026

Resmed launches AirTouch(TM) F40 full face fabric CPAP mask in the U.S.

Resmed launches AirTouch(TM) F40 full face fabric CPAP mask in the U.S. Latest addition to Resmed's growing fabric mask portfolio combines a soft, breathable fabric cushion with a minimalist design for greater comfort and choice. October 19, 2026 08:00 ET | Source: Resmed, Inc. SAN DIEGO, Oct. 19, 2026 (GLOBE NEWSWIRE) - Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and care delivered in the home, today announced the U.S. launch of AirTouch F40, the newest addition to its growing portfolio of fabric continuous positive airway pressure (CPAP) masks. Designed for people with obstructive sleep apnea (OSA) to provide greater comfort and choice in therapy[1], the AirTouch F40 helps address key factors that can influence long-term adherence. OSA is a growing health challenge, affecting more than one billion people worldwide.[2] In the U.S., an estimated 61 million people have OSA, a number projected to rise to nearly 77 million by 2050.[3] CPAP therapy remains the gold standard treatment for OSA[4], and for those on CPAP, mask comfort and fit can play an important role in how people stay engaged with therapy over time. AirTouch F40 brings Resmed's proprietary ComfiSoft(TM) fabric cushion to a minimalist design that is intended to adapt to a person's face as they move throughout the night. Because comfort preferences vary from person to person, expanding mask choice helps give people another option to meet their individual needs. The mask's wide fit range and intuitive design are also intended to make it easier for healthcare providers to help patients find a comfortable fit and support them throughout therapy. AirTouch F40 builds on Resmed's growing portfolio of fabric-based mask technology and reflects the company's commitment to delivering more personalized experiences that support patients throughout their therapy experience. Resmed has seen encouraging outcomes across its fabric mask portfolio, including a 6% increase in 90-day compliance among users of a fabric-cushioned mask compared with users of a silicone-cushioned mask.[5] "AirTouch F40 is one example of how we're continuing to redefine what's possible to create more comfortable and personalized therapy experiences," said Justin Leong, Chief Product Officer at Resmed. "By building on the success of AirFit F40(TM) and introducing a new fabric option, we're giving people greater flexibility to choose the mask that works best for them. That's the kind of innovation that can help more people start and stay on CPAP therapy." Key features of AirTouch F40 include: * Designed to fit and move with the user: AirTouch F40 is designed to fit 96% of people[6] with a minimalist design that adapts to the face as people move throughout the night. * Brings fabric comfort to the full-face experience: The ComfiSoft fabric cushion features soft, breathable, and moisture-wicking fabric[7] designed for comfort against the skin. * A familiar platform for existing AirFit F40 users: The interchangeable cushion allows current AirFit F40 users to try the fabric cushion without changing mask systems or being resized or refitted. Connected support throughout therapy AirTouch F40 is part of Resmed's connected sleep health platform, bringing together devices, digital tools and provider support to create a more connected therapy experience and help people stay engaged over time. Through myAir(TM), Resmed's patient engagement app, people can track their therapy progress, access personalized guidance and receive ongoing support throughout their therapy experience. This includes upcoming features such as Equipment Care, a tool that is designed to encourage patients to take action and stay engaged in managing their CPAP equipment. Healthcare providers can use AirView(TM), Resmed's remote monitoring platform, to view therapy insights and support patients between appointments. When used alongside AirView, myAir has been shown to improve therapy compliance from 70% to 87%.[8] AirTouch F40 will be available in the U.S. beginning October 28, 2026. For more information, visit https://www.resmed.com/en-us/health-professionals/campaigns/airtouch-f40/ About Resmed Resmed (NYSE: RMD, ASX: RMD) creates life-changing health technologies that people love. We're relentlessly committed to pioneering innovative technology to empower millions of people in 140 countries to live happier, healthier lives. Our AI-powered digital health solutions, cloud-connected devices and intelligent software make home healthcare more personalized, accessible and effective. Ultimately, Resmed envisions a world where every person can achieve their full potential through better sleep and breathing, with care delivered in their own home. Learn more about how we're redefining sleep health at Resmed.com and follow @Resmed. For Investors [1] Resmed external crossover study comparing AirTouch F40 mask against other Resmed and third-party masks. n=36. Data on file, ID: A5768170. [2] Benjafield AV, et al. Lancet Respir Med. 2019 Aug; 7(8):687-698. [3] Boers E, et al. Lancet Respir Med. 2025;13(12):1078-1086. [4] Patil SP et al. J Clin Sleep Med. 2019 Feb 15;15(2):301-334. [5] Resmed analysis of 90-day PAP compliance among U.S. patients using AirView(TM) and myAir(TM), comparing AirTouch(TM) N30i and AirFit(TM) N30i. Data on file, ID: A5707362. [6] Internal Resmed analysis of projected cushion fit per region. Data on file, ID: A5756043. [7] Resmed internal testing of the moisture-wicking properties of fabric. Data on file, ID: A5636924. [8] Malhotra et al., CHEST. 2018; 153(4): 843-850.

HEM News

Oct 19th, 2026

Resmed invests in Eight Sleep and links myAir data to its smart mattress app

Eight Sleep and Resmed have formed a partnership to help people in the US and Australia better understand their sleep health. Resmed has also invested in Eight Sleep; the source gives no amount. Users of a Resmed PAP device with the myAir app and an Eight Sleep Pod can now connect their myAir insights to the Eight Sleep app. With the user's permission, the data appears alongside Eight Sleep metrics, so members can track it over time. The integration is live in both countries. The companies plan to expand to more markets. "This collaboration allows Eight Sleep members who use a Resmed PAP device with the myAir app to gain broader insights into their sleep health," said Matteo Franceschetti, co-founder and chief executive officer of Eight Sleep.

Yahoo Finance

Sep 19th, 2026

ResMed achieves 9% revenue growth to $1.5B amid sleep apnea demand, but fiscal 2027 guidance misses expectations

ResMed Inc. (NYSE: RMD) is positioned to benefit from growing awareness and penetration in the global obstructive sleep apnea treatment market, backed by its robust product portfolio. The portfolio includes CPAP and APAP machines, led by the AirSense platform, along with masks and accessories. In the fourth quarter of fiscal 2026, ResMed's revenue increased 9% year over year to $1.5 billion. Americas device revenue rose 6%, whilst total Americas Sleep and Breathing Health revenue increased 8%. On 15 September, RBC Capital upgraded ResMed to Outperform, raising its price target to $262 from $244. However, the company faces competitive pressures, particularly from the potential return of Philips Respironics to the US market. ResMed issued 2027 revenue guidance of $5.75 billion to $5.85 billion, below analysts' expectations of $5.92 billion.

Yahoo Finance

Sep 14th, 2026

ResMed falls 20.5% over 52 weeks despite Q4 revenue beat amid margin compression

ResMed, a San Diego-based developer of medical devices for respiratory disorders, has underperformed the healthcare sector over the past year. The company, valued at $31.5 billion, has declined 20.5% over 52 weeks, whilst the State Street Healthcare Select Sector SPDR ETF rose 21% during the same period. The stock fell 5.1% on 7 August following its Q4 earnings release. Whilst revenue increased 8.6% year-over-year and adjusted earnings per share of $2.95 beat forecasts, operating margin compressed to 30.7% from 33.7% the previous year. Management attributed the margin decline to higher R&D and supply chain costs amid inflation. Despite recent underperformance, the stock has gained 13.5% over the past three months. Wall Street analysts maintain a "moderate buy" rating, with a mean price target suggesting 9.1% upside potential.

Resmed

Senior Analyst - Data Integrity, Enablement & Validation

About the job

About the company

Get referred to Resmed

Simplify's Take

What believers are saying

What critics are saying

What makes Resmed unique

Benefits

Growth & Insights and Company News

6 month growth

1 year growth

2 year growth